Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05905016 · ClinicalTrials.gov registry record

Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders

A clinical trial of Gastroparesis and Achalasia, sponsored by AdventHealth.

Recruiting
Registry status
600
Enrollment target
1
Study location

NCT05905016: Recruiting study of Gastroparesis and Achalasia, sponsored by AdventHealth.

NCT05905016 is a study of Gastroparesis and Achalasia that is actively recruiting participants, run by AdventHealth. The registered enrollment target is 600 participants, above the 289-participant average among 44 other Gastroparesis trials with a reported enrollment target (108% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05905016, a study of Gastroparesis and Achalasia, is actively recruiting participants, sponsored by AdventHealth.

RECRUITING
Registry status
600 participants
Enrollment target
1
Study location

Study Summary

This is prospective data recording study. All patients will receive standard medical care and no experimental interventions will be performed.

Primary Outcome

Rate of Long-Term Clinical Success and Post-procedural Reflux Rate Among Patients with Esophageal Dysmotility Undergoing POEM

Study Locations (1)

Florida

  • AdventHealth Orlando - Orlando

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2021-10-01
Est. Completion 2027-04
AdventHealth

95 total trials

What NCT05905016 shows while recruiting

NCT05905016 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 289-participant average among 44 other Gastroparesis trials with a reported enrollment target (108% higher).

The record links to 5 conditions, with Gastroparesis appearing as the primary indexed condition, and to 0 interventions.

NCT05905016 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT05905016 about?

NCT05905016 is a clinical study titled "Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders". This is prospective data recording study. All patients will receive standard medical care and no experimental interventions will be performed.

What is the current status of trial NCT05905016?

This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2021-10-01. Estimated completion is 2027-04.

What conditions does trial NCT05905016 study?

This clinical trial studies the following conditions: Gastroparesis, Achalasia, Zenker Diverticulum, Esophageal Spasm, Diffuse, Swallowing Disorder.

Who is sponsoring clinical trial NCT05905016?

This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05905016 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastroparesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05905016's enrollment target sits among peer trials

600 4th of 44 higher than 41 of 44 other Gastroparesis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Gastroparesis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05905016, the US trial registry maintained by the National Library of Medicine. NCT05905016 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.